Analyse and give detailed reporting
| # | Test | Result | Reference | Status |
|---|---|---|---|---|
| 1 | ESR | 20.00 | 0-12 | โฌ HIGH |
| 2 | HbA1c | 6.80% | <5.7% (non-diabetic) | โฌ HIGH (Diabetic range) |
| 3 | Mean Plasma Glucose | 148.46 mg/dL | 0-116 | โฌ HIGH |
| 4 | Fasting Plasma Glucose | 118.00 mg/dL | 74-99 | โฌ HIGH (Impaired fasting) |
| 5 | Total Cholesterol | 235.00 mg/dL | <200 | โฌ HIGH (Moderate risk) |
| 6 | Triglycerides | 200.00 mg/dL | <150 | โฌ HIGH |
| 7 | LDL Cholesterol | 164.00 mg/dL | <100 (optimal) | โฌ HIGH |
| 8 | VLDL Cholesterol | 40.00 mg/dL | 10-35 | โฌ HIGH |
| 9 | Non-HDL Cholesterol | 192.30 mg/dL | <130 | โฌ HIGH |
| 10 | Total Cholesterol/HDL Ratio | 5.50 | 3.3-4.4 (low risk) | โฌ ABOVE low risk range |
| 11 | LDL/HDL Ratio | 3.84 | 0.5-3.0 (low risk) | โฌ Moderate risk |
| 12 | % Iron Saturation | 17.99% | 20-50% | โฌ LOW |
| 13 | Absolute Monocyte Count | 175/ยตL | 200-1000 | โฌ LOW |
| 14 | Vitamin B12 | 116 pg/mL | 191-663 | โฌ LOW |
| 15 | Vitamin D (25-OH) | 26.40 ng/mL | 30-100 (sufficient) | โฌ INSUFFICIENT |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Haemoglobin | 13.80 g/dL | 13-17 | โ Normal |
| Total WBC (TLC) | 8.75 thou/ยตL | 4-10 | โ Normal |
| Neutrophils | 68% | 40-80% | โ Normal |
| Lymphocytes | 29% | 20-40% | โ Normal |
| Eosinophils | 1% | 1-6% | โ Normal |
| Monocytes | 2% | 2-10% | โ Normal |
| Basophils | 0% | 0-2% | โ Normal |
| ANC | 5950/ยตL | 2000-7000 | โ Normal |
| Absolute Lymphocyte Count | 2537.50/ยตL | 1000-3000 | โ Normal |
| Absolute Eosinophil Count | 87.50/ยตL | 20-500 | โ Normal |
| Absolute Monocyte Count | 175/ยตL | 200-1000 | โฌ Slightly Low |
| RBC | 4.72 million/ยตL | 4.5-5.5 | โ Normal |
| PCV/Hematocrit | 40.40% | 40-50% | โ Low-normal |
| MCV | 85.50 fL | 83-101 | โ Normal |
| MCH | 29.20 pg | 27-32 | โ Normal |
| MCHC | 34.10 g/dL | 31.5-34.5 | โ Normal |
| RDW | 14.50% | 11.8-15.6% | โ Normal |
| Platelet Count | 236 thou/ยตL | 150-410 | โ Normal |
| MPV | 9.50 fL | 6.8-10.9 | โ Normal |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| ESR | 20.00 | 0-12 | โฌ HIGH (66% above upper limit) |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| HbA1c | 6.80% | <5.7% (non-diabetic) | โฌ DIABETIC RANGE (โฅ6.5%) |
| Mean Plasma Glucose | 148.46 mg/dL | 0-116 | โฌ HIGH |
| Fasting Plasma Glucose | 118.00 mg/dL | 74-99 (normal) | โฌ Impaired fasting glucose (100-125) |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Total Cholesterol | 235 mg/dL | <200 (no risk) | โฌ Moderate risk (200-239) |
| Triglycerides | 200 mg/dL | <150 | โฌ High (at upper boundary of "High" range: 200-499) |
| LDL Cholesterol (Direct) | 164 mg/dL | <100 (optimal) | โฌ High (161-189 = High) |
| HDL Cholesterol | 42.70 mg/dL | 40-60 (optimal) | โ Low-normal (borderline) |
| VLDL | 40.00 mg/dL | 10-35 | โฌ HIGH |
| Non-HDL Cholesterol | 192.30 mg/dL | <130 | โฌ HIGH |
| TC/HDL Ratio | 5.50 | 3.3-4.4 (low risk) | โฌ Above low-risk zone |
| LDL/HDL Ratio | 3.84 | 0.5-3.0 (low risk) | โฌ Moderate risk (3.1-6.0) |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Bilirubin Total | 0.35 mg/dL | 0-1.2 | โ Normal |
| Bilirubin Direct | 0.16 mg/dL | 0-0.2 | โ Normal |
| Bilirubin Indirect | 0.18 mg/dL | 0-0.9 | โ Normal |
| SGOT/AST | 18.80 U/L | 0-40 | โ Normal |
| SGPT/ALT | 20.60 U/L | 0-41 | โ Normal |
| AST/ALT Ratio | 0.91 | - | โ Normal |
| ALP | 99.70 U/L | 40-129 | โ Normal |
| Total Protein | 6.77 g/dL | 6.4-8.3 | โ Normal |
| Albumin | 4.41 g/dL | 3.97-4.94 | โ Normal |
| Globulin | 2.36 g/dL | 1.9-3.7 | โ Normal |
| A/G Ratio | 1.87 | 1.0-2.1 | โ Normal |
| GGT | 21.20 U/L | 10-71 | โ Normal |
| LDH | 183.00 U/L | 135-225 | โ Normal |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Serum Iron | 60.10 ยตg/dL | 59-158 | โ Low-normal (barely in range) |
| UIBC | 274.00 ยตg/dL | 110-370 | โ Normal |
| TIBC | 334.10 ยตg/dL | 228-428 | โ Normal |
| % Saturation | 17.99% | 20-50% | โฌ LOW |
| Ferritin | 81.50 ng/mL | 30-400 | โ Normal |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Total T3 | 1.23 ng/mL | 0.8-2.0 | โ Normal |
| Total T4 | 10.40 ยตg/dL | 5.1-14.1 | โ Normal |
| TSH (3rd Gen) | 2.550 ยตIU/mL | 0.27-4.2 | โ Normal |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Vitamin B12 / Cobalamin | 116 pg/mL | 191-663 | โฌ DEFICIENT (39% below lower limit) |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Vitamin D (25-OH) | 26.40 ng/mL | 30-100 (sufficient) | โฌ INSUFFICIENT (20-30 = Insufficiency range) |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Blood Urea Nitrogen | 10.75 mg/dL | 8.41-25.7 | โ Normal |
| Blood Urea | 23.00 mg/dL | 18-55 | โ Normal |
| Creatinine | 0.70 mg/dL | 0.7-1.3 | โ Normal (lower boundary) |
| BUN/Creatinine Ratio | 15.42 | 10-20 | โ Normal |
| Uric Acid | 4.40 mg/dL | 3.4-7.0 | โ Normal |
| Sodium | 139.20 mmol/L | 136-145 | โ Normal |
| Potassium | 4.12 mmol/L | 3.5-5.1 | โ Normal |
| Chloride | 103.70 mmol/L | 97-107 | โ Normal |
| Calcium | 9.12 mg/dL | 8.8-10.2 | โ Normal |
| Phosphorus | 2.77 mg/dL | 2.5-4.5 | โ Normal |
| eGFR (Male) | 105.62 mL/min/1.73mยฒ | >90 Normal | โ Normal GFR |
| Parameter | Result | Reference | Assessment |
|---|---|---|---|
| Microalbumin (urine) | 1.20 mg/L | 0-20 | โ Normal |
| Creatinine (urine) | 51.90 mg/dL | 39-259 | โ Normal |
| Albumin/Creatinine Ratio (ACR) | 2.31 mg/g | 0-30 | โ Normal |
| Parameter | Result | Assessment |
|---|---|---|
| Colour | Pale Yellow | โ Normal |
| Appearance | Clear | โ Normal |
| Specific Gravity | 1.015 | โ Normal |
| pH | 6.00 | โ Normal |
| Glucose | Not Detected | โ Normal |
| Protein | Not Detected | โ Normal |
| Ketones | Not Detected | โ Normal |
| Blood | Not Detected | โ Normal |
| Leucocytes | Not Detected | โ Normal |
| Bilirubin | Not Detected | โ Normal |
| Urobilinogen | Normal | โ Normal |
| Nitrite | Not Detected | โ Normal |
| Pus Cells | 1-2/hpf | โ Normal (0-5) |
| RBC | Not Detected | โ Normal |
| Epithelial Cells | 3-5/hpf | โ Normal (0-5) |
| Casts | Not Detected | โ Normal |
| Crystals | Not Detected | โ Normal |
| Bacteria | Not Detected | โ Normal |
| Test | Reason |
|---|---|
| HbA1c repeat | In 3 months per ADA guidelines |
| Lipid profile repeat | After dietary/statin intervention (6-8 weeks) |
| B12 level repeat | After supplementation (3 months) |
| Vitamin D repeat | After supplementation (3 months) |
| Fasting + post-prandial glucose | Detailed glycaemic monitoring |
| OGTT (if not diagnosed yet) | Confirm diabetes status |
| CRP / hs-CRP | To quantify inflammatory/cardiovascular risk |
| ECG / Echo | Given high CV risk profile |
| HbA1c + Creatinine + ACR | Annual diabetic panel |
| Blood pressure monitoring | Standard care for diabetic patient |
Disclaimer: This analysis is for informational and educational purposes only. All findings must be interpreted by the treating physician (Dr. Devansh Sharma) in the context of the patient's symptoms, medical history, and clinical examination. Do not start or stop any medication based on this report alone.
Create a summary document highlighting abnormal findings and management recommendations
Chander Sharma Clinical Summary
Word Document ยท DOCX
| Section | Content |
|---|---|
| 1. Executive Summary | Narrative overview of the key findings with red/orange alert boxes for the most urgent issues |
| 2. Abnormal Results Table | All 15 flagged parameters in a colour-coded table (red = critical, orange = watch) with results vs references vs status |
| 3. Domain Analysis | Five clinical panels analysed in detail: Glycaemic Status, Lipid Profile, B12 & Vitamin D, Iron Studies, ESR |
| 4. Normal Findings | Consolidated reassurance table showing all normal systems (CBC, LFT, KFT, thyroid, urine, HBsAg) |
| 5. Management Recommendations | Six prioritised action tables covering diabetes, dyslipidaemia, B12, Vitamin D, iron, and inflammation |
| 6. Follow-Up Plan | Structured table of 10 recommended tests/actions with timeline and clinical reason |
| 7. Disclaimer | Medico-legal disclaimer with lab authentication details |